Opiant Pharmaceuticals Current Ratio 2014-2019 | OPNT

Opiant Pharmaceuticals current ratio from 2014 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Opiant Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.03B $0.01B 3.28
2019-03-31 $0.03B $0.01B 2.77
2018-12-31 $0.03B $0.01B 2.99
2018-09-30 $0.03B $0.00B 7.86
2018-06-30 $0.02B $0.00B 3.41
2018-03-31 $0.01B $0.01B 2.43
2017-12-31 $0.02B $0.01B 3.67
2017-10-31 $0.01B $0.00B 1.56
2017-09-30 $0.00B 0.00
2017-07-31 $0.01B $0.00B 2.72
2017-06-30 $0.00B 0.00
2017-04-30 $0.01B $0.00B 3.13
2017-03-31 $0.00B 0.00
2017-01-31 $0.01B $0.01B 2.50
2016-10-31 $0.00B $0.01B 0.41
2016-07-31 $0.00B $0.00B 0.44
2016-04-30 $0.00B $0.00B 0.60
2016-01-31 $0.00B $0.00B 0.34
2015-10-31 $0.00B $0.00B 0.13
2015-07-31 $0.00B $0.00B 0.13
2015-04-30 $0.00B $0.00B 0.56
2015-01-31 $0.00B $0.00B 0.47
2014-10-31 $0.00B $0.00B 0.82
2014-09-30 $0.00B 0.00
2014-07-31 $0.00B $0.00B 0.14
2014-06-30 $0.00B $0.00B 0.14
2014-04-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2014-01-31 $0.00B 0.00
2013-12-31 $0.00B 0.00
2013-10-31 $0.00B 0.00
2013-09-30 $0.00B $0.00B 0.69
2013-06-30 $0.00B $0.00B 0.69
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.055B $0.014B
Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Pharmaceuticals Inc., formerly known as Lightlake Therapeutics, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.454B 37.23
Takeda Pharmaceutical (TAK) Japan $53.771B 8.41
Astellas Pharma (ALPMY) Japan $29.086B 13.86
Merck (MKGAF) Germany $14.682B 20.03
Eisai (ESALY) Japan $14.552B 22.28
Grifols, S.A (GRFS) Spain $14.047B 17.92
UCB SA (UCBJF) Belgium $13.839B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.785B 18.95
Neurocrine Biosciences (NBIX) United States $8.326B 0.00
IPSEN SA ADR (IPSEY) France $7.776B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Sage Therapeutics (SAGE) United States $7.197B 0.00
Catalent (CTLT) United States $7.070B 27.94
Jazz Pharmaceuticals (JAZZ) Ireland $6.661B 8.77
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.118B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.172B 18.59
United Therapeutics (UTHR) United States $3.563B 0.00
FibroGen (FGEN) United States $3.305B 82.67
Evotec AG (EVTCY) Germany $3.277B 44.87
Arrowhead Pharmaceuticals (ARWR) United States $3.127B 71.70
Taro Pharmaceutical Industries (TARO) Israel $2.863B 10.26
Nektar Therapeutics (NKTR) United States $2.782B 0.00
PTC Therapeutics (PTCT) United States $2.175B 0.00
Tilray (TLRY) Canada $2.017B 0.00
Xencor (XNCR) United States $1.925B 41.97
Portola Pharmaceuticals (PTLA) United States $1.835B 0.00
Zogenix (ZGNX) United States $1.835B 0.00
Corcept Therapeutics (CORT) United States $1.597B 21.95
USANA Health Sciences (USNA) United States $1.529B 15.33
Pacira Pharmaceuticals (PCRX) United States $1.524B 55.47
Heron Therapeutics (HRTX) United States $1.413B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.362B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.155B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.147B 18.92
ArQule (ARQL) United States $1.017B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.974B 0.00
TherapeuticsMD (TXMD) United States $0.948B 0.00
Aerie Pharmaceuticals (AERI) United States $0.905B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.837B 0.00
Dova Pharmaceuticals (DOVA) United States $0.810B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.808B 3.60
Endo (ENDP) Ireland $0.761B 1.34
Organogenesis Holdings (ORGO) United States $0.719B 0.00
Concordia (CXRXF) Canada $0.633B 0.00
Karyopharm Therapeutics (KPTI) United States $0.626B 0.00
Flexion Therapeutics (FLXN) United States $0.526B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.510B 0.00
Akebia Therapeutics (AKBA) United States $0.493B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.458B 0.00
Siga Technologies (SIGA) United States $0.440B 1.03
Lannett Co Inc (LCI) United States $0.437B 4.60
Indivior (INVVY) United States $0.437B 1.58
ChemoCentryx (CCXI) United States $0.422B 0.00
Translate Bio (TBIO) United States $0.409B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.402B 0.00
Collegium Pharmaceutical (COLL) United States $0.394B 0.00
Innate Pharma SA (IPHYF) France $0.392B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.366B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.365B 16.61
ImmunoGen (IMGN) United States $0.346B 0.00
DURECT (DRRX) United States $0.346B 0.00
Rafael Holdings (RFL) United States $0.320B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.301B 0.00
Dermira (DERM) United States $0.289B 0.00
OptiNose (OPTN) United States $0.282B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
Ardelyx (ARDX) United States $0.276B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.264B 0.00
Recro Pharma (REPH) United States $0.248B 0.00
Molecular Templates (MTEM) United States $0.247B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.231B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.209B 0.00
Xeris Pharmaceuticals (XERS) United States $0.208B 0.00
GlycoMimetics (GLYC) United States $0.193B 0.00
KalVista Pharmaceuticals (KALV) United States $0.191B 0.00
CV Sciences (CVSI) United States $0.185B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 28.55
Taiwan Liposome (TLC) Taiwan $0.169B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Ocular Therapeutix (OCUL) United States $0.144B 0.00
IMV INC (IMV) Canada $0.141B 0.00
Concert Pharmaceuticals (CNCE) United States $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.138B 0.00
Calithera Biosciences (CALA) United States $0.137B 0.00
Generex Biotechnology (GNBT) United States $0.131B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.131B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.125B 0.00
MEI Pharma (MEIP) United States $0.118B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.111B 0.00
Jounce Therapeutics (JNCE) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 33.71
Cardiome Pharma (CORV) Canada $0.086B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
Aquestive Therapeutics (AQST) United States $0.080B 0.00
Majesco Entertainment (PTE) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Lipocine (LPCN) United States $0.071B 0.00
Otonomy (OTIC) United States $0.069B 0.00
AgeX Therapeutics (AGE) United States $0.068B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
RENEURON GP (RNUGF) United Kingdom $0.065B 0.00
Novan (NOVN) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.062B 9.35
IntelGenx Technologies (IGXT) Canada $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Aclaris Therapeutics (ACRS) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.058B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.054B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.052B 0.00
Capnia (SLNO) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Mast Therapeutics (SVRA) United States $0.036B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
PharmAthene (ALT) United States $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Opexa Therapeutics (ACER) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 17.29
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00